{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:12:23Z","timestamp":1757542343003},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,3,17]],"date-time":"2012-03-17T00:00:00Z","timestamp":1331942400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Angiogenesis"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s10456-012-9263-3","type":"journal-article","created":{"date-parts":[[2012,3,16]],"date-time":"2012-03-16T13:25:21Z","timestamp":1331904321000},"page":"305-316","source":"Crossref","is-referenced-by-count":33,"title":["A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors"],"prefix":"10.1007","volume":"15","author":[{"given":"Maddalena","family":"Arigoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina","family":"Barutello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Lanzardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvio","family":"Aime","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Curcio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Iezzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irmeli","family":"Barkefors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Holmgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Cavallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,17]]},"reference":[{"issue":"9","key":"9263_CR1","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/nrc2208","volume":"7","author":"F Cavallo","year":"2007","unstructured":"Cavallo F, Calogero RA, Forni G (2007) Are oncoantigens suitable targets for anti-tumour therapy? Nat Rev Cancer 7(9):707\u2013713. doi:\n                    10.1038\/nrc2208","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"9263_CR2","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1084\/jem.194.9.1195","volume":"194","author":"P Nanni","year":"2001","unstructured":"Nanni P, Nicoletti G, De Giovanni C, Landuzzi L, Di Carlo E, Cavallo F, Pupa SM, Rossi I, Colombo MP, Ricci C, Astolfi A, Musiani P, Forni G, Lollini PL (2001) Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2\/neu transgenic mice. J Exp Med 194(9):1195\u20131205","journal-title":"J Exp Med"},{"issue":"7","key":"9263_CR3","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1158\/0008-5472.CAN-09-2548","volume":"70","author":"E Quaglino","year":"2010","unstructured":"Quaglino E, Mastini C, Amici A, Marchini C, Iezzi M, Lanzardo S, De Giovanni C, Montani M, Lollini PL, Masucci G, Forni G, Cavallo F (2010) A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat\/human chimeric proteins. Cancer Res 70(7):2604\u20132612. doi:\n                    10.1158\/0008-5472.CAN-09-2548","journal-title":"Cancer Res"},{"key":"9263_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0065-2776(06)90005-4","volume":"90","author":"F Cavallo","year":"2006","unstructured":"Cavallo F, Offringa R, van der Burg SH, Forni G, Melief CJ (2006) Vaccination for treatment and prevention of cancer in animal models. Adv Immunol 90:175\u2013213. doi:\n                    10.1016\/S0065-2776(06)90005-4","journal-title":"Adv Immunol"},{"issue":"6","key":"9263_CR5","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nm1769","volume":"14","author":"R Chiarle","year":"2008","unstructured":"Chiarle R, Martinengo C, Mastini C, Ambrogio C, D\u2019Escamard V, Forni G, Inghirami G (2008) The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination. Nat Med 14(6):676\u2013680. doi:\n                    10.1038\/nm1769","journal-title":"Nat Med"},{"issue":"2","key":"9263_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S1471-4906(02)00030-3","volume":"24","author":"PL Lollini","year":"2003","unstructured":"Lollini PL, Forni G (2003) Cancer immunoprevention: tracking down persistent tumor antigens. Trends Immunol 24(2):62\u201366. doi:\n                    S1471490602000303","journal-title":"Trends Immunol"},{"issue":"3","key":"9263_CR7","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrc1815","volume":"6","author":"PL Lollini","year":"2006","unstructured":"Lollini PL, Cavallo F, Nanni P, Forni G (2006) Vaccines for tumour prevention. Nat Rev Cancer 6(3):204\u2013216. doi:\n                    10.1038\/nrc1815","journal-title":"Nat Rev Cancer"},{"issue":"24","key":"9263_CR8","doi-asserted-by":"publisher","first-page":"9208","DOI":"10.1073\/pnas.0603110103","volume":"103","author":"L Holmgren","year":"2006","unstructured":"Holmgren L, Ambrosino E, Birot O, Tullus C, Veitonmaki N, Levchenko T, Carlson LM, Musiani P, Iezzi M, Curcio C, Forni G, Cavallo F, Kiessling R (2006) A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth. Proc Natl Acad Sci USA 103(24):9208\u20139213. doi:\n                    10.1073\/pnas.0603110103","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"9263_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","volume":"86","author":"D Hanahan","year":"1996","unstructured":"Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86(3):353\u2013364. doi:\n                    S0092-8674(00)80108-710","journal-title":"Cell"},{"issue":"2","key":"9263_CR10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/nm0295-149","volume":"1","author":"L Holmgren","year":"1995","unstructured":"Holmgren L, O\u2019Reilly MS, Folkman J (1995) Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1(2):149\u2013153","journal-title":"Nat Med"},{"issue":"6","key":"9263_CR11","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1083\/jcb.152.6.1247","volume":"152","author":"B Troyanovsky","year":"2001","unstructured":"Troyanovsky B, Levchenko T, Mansson G, Matvijenko O, Holmgren L (2001) Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation. J Cell Biol 152(6):1247\u20131254","journal-title":"J Cell Biol"},{"issue":"1","key":"9263_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0378-1119(02)00928-9","volume":"298","author":"A Bratt","year":"2002","unstructured":"Bratt A, Wilson WJ, Troyanovsky B, Aase K, Kessler R, Van Meir EG, Holmgren L (2002) Angiomotin belongs to a novel protein family with conserved coiled-coil and PDZ binding domains. Gene 298(1):69\u201377. doi:\n                    S0378111902009289","journal-title":"Gene"},{"issue":"7","key":"9263_CR13","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1038\/sj.onc.1207264","volume":"23","author":"T Levchenko","year":"2004","unstructured":"Levchenko T, Bratt A, Arbiser JL, Holmgren L (2004) Angiomotin expression promotes hemangioendothelioma invasion. Oncogene 23(7):1469\u20131473. doi:\n                    10.1038\/sj.onc.1207264","journal-title":"Oncogene"},{"issue":"3","key":"9263_CR14","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.bbamcr.2007.11.018","volume":"1783","author":"M Ernkvist","year":"2008","unstructured":"Ernkvist M, Birot O, Sinha I, Veitonmaki N, Nystrom S, Aase K, Holmgren L (2008) Differential roles of p80- and p130-angiomotin in the switch between migration and stabilization of endothelial cells. Biochim Biophys Acta 1783(3):429\u2013437. doi:\n                    10.1016\/j.bbamcr.2007.11.018","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"9263_CR15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1084\/jem.188.3.589","volume":"188","author":"K Boggio","year":"1998","unstructured":"Boggio K, Nicoletti G, Di Carlo E, Cavallo F, Landuzzi L, Melani C, Giovarelli M, Rossi I, Nanni P, De Giovanni C, Bouchard P, Wolf S, Modesti A, Musiani P, Lollini PL, Colombo MP, Forni G (1998) Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2\/neu transgenic mice. J Exp Med 188(3):589\u2013596","journal-title":"J Exp Med"},{"issue":"9","key":"9263_CR16","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.4049\/jimmunol.165.9.5133","volume":"165","author":"S Rovero","year":"2000","unstructured":"Rovero S, Amici A, Carlo ED, Bei R, Nanni P, Quaglino E, Porcedda P, Boggio K, Smorlesi A, Lollini PL, Landuzzi L, Colombo MP, Giovarelli M, Musiani P, Forni G (2000) DNA vaccination against rat her-2\/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB\/c mice. J Immunol 165(9):5133\u20135142","journal-title":"J Immunol"},{"issue":"9","key":"9263_CR17","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1111\/j.1742-4658.2006.05216.x","volume":"273","author":"M Ernkvist","year":"2006","unstructured":"Ernkvist M, Aase K, Ukomadu C, Wohlschlegel J, Blackman R, Veitonmaki N, Bratt A, Dutta A, Holmgren L (2006) p130-angiomotin associates to actin and controls endothelial cell shape. FEBS J 273(9):2000\u20132011. doi:\n                    10.1111\/j.1742-4658.2006.05216.x","journal-title":"FEBS J"},{"issue":"Suppl 2","key":"9263_CR18","doi-asserted-by":"publisher","first-page":"S491","DOI":"10.1016\/S1076-6332(03)80273-8","volume":"9","author":"FM Cavagna","year":"2002","unstructured":"Cavagna FM, Lorusso V, Anelli PL, Maggioni F, de Haen C (2002) Preclinical profile and clinical potential of gadocoletic acid trisodium salt (B22956\/1), a new intravascular contrast medium for MRI. Acad Radiol 9(Suppl 2):S491\u2013S494","journal-title":"Acad Radiol"},{"issue":"1","key":"9263_CR19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/jmri.20061","volume":"20","author":"M Medved","year":"2004","unstructured":"Medved M, Karczmar G, Yang C, Dignam J, Gajewski TF, Kindler H, Vokes E, MacEneany P, Mitchell MT, Stadler WM (2004) Semiquantitative analysis of dynamic contrast enhanced MRI in cancer patients: Variability and changes in tumor tissue over time. J Magn Reson Imaging 20(1):122\u2013128. doi:\n                    10.1002\/jmri.20061","journal-title":"J Magn Reson Imaging"},{"issue":"8","key":"9263_CR20","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1158\/0008-5472.CAN-03-2962","volume":"64","author":"E Quaglino","year":"2004","unstructured":"Quaglino E, Iezzi M, Mastini C, Amici A, Pericle F, Di Carlo E, Pupa SM, De Giovanni C, Spadaro M, Curcio C, Lollini PL, Musiani P, Forni G, Cavallo F (2004) Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2\/neu transgenic mice. Cancer Res 64(8):2858\u20132864","journal-title":"Cancer Res"},{"issue":"7","key":"9263_CR21","first-page":"2809","volume":"61","author":"L Cifaldi","year":"2001","unstructured":"Cifaldi L, Quaglino E, Di Carlo E, Musiani P, Spadaro M, Lollini PL, Wolf S, Boggio K, Forni G, Cavallo F (2001) A light, nontoxic interleukin 12 protocol inhibits HER-2\/neu mammary carcinogenesis in BALB\/c transgenic mice with established hyperplasia. Cancer Res 61(7):2809\u20132812","journal-title":"Cancer Res"},{"issue":"11","key":"9263_CR22","doi-asserted-by":"publisher","first-page":"6124","DOI":"10.4049\/jimmunol.0901215","volume":"184","author":"S Rolla","year":"2010","unstructured":"Rolla S, Ria F, Occhipinti S, Di Sante G, Iezzi M, Spadaro M, Nicolo C, Ambrosino E, Merighi IF, Musiani P, Forni G, Cavallo F (2010) Erbb2 DNA vaccine combined with regulatory T cell deletion enhances antibody response and reveals latent low-avidity T cells: potential and limits of its therapeutic efficacy. J Immunol 184(11):6124\u20136132. doi:\n                    10.4049\/jimmunol.0901215","journal-title":"J Immunol"},{"issue":"5","key":"9263_CR23","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/S0002-9440(10)63568-7","volume":"163","author":"EY Lin","year":"2003","unstructured":"Lin EY, Jones JG, Li P, Zhu L, Whitney KD, Muller WJ, Pollard JW (2003) Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am J Pathol 163(5):2113\u20132126. doi:\n                    10.1016\/S0002-9440(10)63568-7","journal-title":"Am J Pathol"},{"issue":"7","key":"9263_CR24","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nm.2161","volume":"16","author":"R Jaini","year":"2010","unstructured":"Jaini R, Kesaraju P, Johnson JM, Altuntas CZ, Jane-Wit D, Tuohy VK (2010) An autoimmune-mediated strategy for prophylactic breast cancer vaccination. Nat Med 16(7):799\u2013803. doi:\n                    10.1038\/nm.2161","journal-title":"Nat Med"},{"issue":"1","key":"9263_CR25","first-page":"261","volume":"180","author":"JW Ding","year":"2008","unstructured":"Ding JW, Zhou T, Zeng H, Ma L, Verbeek JS, Yin D, Shen J, Chong AS (2008) Hyperacute rejection by anti-Gal IgG1, IgG2a, and IgG2b is dependent on complement and Fc-gamma receptors. J Immunol 180(1):261\u2013268. doi:\n                    180\/1\/26126","journal-title":"J Immunol"},{"issue":"45","key":"9263_CR26","doi-asserted-by":"publisher","first-page":"19396","DOI":"10.1073\/pnas.1014515107","volume":"107","author":"F Nimmerjahn","year":"2010","unstructured":"Nimmerjahn F, Lux A, Albert H, Woigk M, Lehmann C, Dudziak D, Smith P, Ravetch JV (2010) FcgammaRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo. Proc Natl Acad Sci USA 107(45):19396\u201319401. doi:\n                    10.1073\/pnas.1014515107","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"9263_CR27","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1172\/JCI17426","volume":"111","author":"C Curcio","year":"2003","unstructured":"Curcio C, Di Carlo E, Clynes R, Smyth MJ, Boggio K, Quaglino E, Spadaro M, Colombo MP, Amici A, Lollini PL, Musiani P, Forni G (2003) Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2\/neu carcinomas. J Clin Invest 111(8):1161\u20131170. doi:\n                    10.1172\/JCI17426","journal-title":"J Clin Invest"},{"key":"9263_CR28","doi-asserted-by":"publisher","unstructured":"Quaglino E, Mastini C, Forni G, Cavallo F (2008) ErbB2 transgenic mice: a tool for investigation of the immune prevention and treatment of mammary carcinomas. Curr Protoc Immunol Chapter 20:Unit 20 29 21-20 29-10. doi:\n                    10.1002\/0471142735.im2009s82","DOI":"10.1002\/0471142735.im2009s82"},{"issue":"3","key":"9263_CR29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00262-010-0968-0","volume":"60","author":"F Cavallo","year":"2011","unstructured":"Cavallo F, De Giovanni C, Nanni P, Forni G, Lollini PL (2011) 2011: the immune hallmarks of cancer. Cancer Immunol Immunother 60(3):319\u2013326. doi:\n                    10.1007\/s00262-010-0968-0","journal-title":"Cancer Immunol Immunother"},{"issue":"8","key":"9263_CR30","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00262-008-0452-2","volume":"57","author":"J Pan","year":"2008","unstructured":"Pan J, Jin P, Yan J, Kabelitz D (2008) Anti-angiogenic active immunotherapy: a new approach to cancer treatment. Cancer Immunol Immunother 57(8):1105\u20131114. doi:\n                    10.1007\/s00262-008-0452-2","journal-title":"Cancer Immunol Immunother"},{"key":"9263_CR31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-2407-6-16","volume":"6","author":"WG Jiang","year":"2006","unstructured":"Jiang WG, Watkins G, Douglas-Jones A, Holmgren L, Mansel RE (2006) Angiomotin and angiomotin like proteins, their expression and correlation with angiogenesis and clinical outcome in human breast cancer. BMC Cancer 6:16. doi:\n                    10.1186\/1471-2407-6-16","journal-title":"BMC Cancer"},{"issue":"3","key":"9263_CR32","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1096\/fj.07-9509com","volume":"22","author":"T Levchenko","year":"2008","unstructured":"Levchenko T, Veitonmaki N, Lundkvist A, Gerhardt H, Ming Y, Berggren K, Kvanta A, Carlsson R, Holmgren L (2008) Therapeutic antibodies targeting angiomotin inhibit angiogenesis in vivo. FASEB J 22(3):880\u2013889. doi:\n                    10.1096\/fj.07-9509com","journal-title":"FASEB J"},{"issue":"20","key":"9263_CR33","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1200\/JCO.2006.06.8080","volume":"24","author":"N Hylton","year":"2006","unstructured":"Hylton N (2006) Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J Clin Oncol 24(20):3293\u20133298. doi:\n                    10.1200\/JCO.2006.06.8080","journal-title":"J Clin Oncol"},{"issue":"28","key":"9263_CR34","doi-asserted-by":"publisher","first-page":"4572","DOI":"10.1200\/JCO.2007.15.5655","volume":"26","author":"OM Hahn","year":"2008","unstructured":"Hahn OM, Yang C, Medved M, Karczmar G, Kistner E, Karrison T, Manchen E, Mitchell M, Ratain MJ, Stadler WM (2008) Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma. J Clin Oncol 26(28):4572\u20134578. doi:\n                    10.1200\/JCO.2007.15.5655","journal-title":"J Clin Oncol"},{"issue":"16","key":"9263_CR35","doi-asserted-by":"publisher","first-page":"5827","DOI":"10.1158\/1078-0432.CCR-04-2655","volume":"11","author":"P Marzola","year":"2005","unstructured":"Marzola P, Degrassi A, Calderan L, Farace P, Nicolato E, Crescimanno C, Sandri M, Giusti A, Pesenti E, Terron A, Sbarbati A, Osculati F (2005) Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma. Clin Cancer Res 11(16):5827\u20135832. doi:\n                    10.1158\/1078-0432.CCR-04-2655","journal-title":"Clin Cancer Res"},{"issue":"6","key":"9263_CR36","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/cmmi.436","volume":"6","author":"S Geninatti-Crich","year":"2011","unstructured":"Geninatti-Crich S, Szabo I, Alberti D, Longo D, Aime S (2011) MRI of cells and mice at 1 and 7 Tesla with Gd-targeting agents: when the low field is better! Contrast Media Mol Imaging 6(6):421\u2013425. doi:\n                    10.1002\/cmmi.436","journal-title":"Contrast Media Mol Imaging"},{"issue":"2","key":"9263_CR37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10456-010-9170-4","volume":"13","author":"K Vandoorne","year":"2010","unstructured":"Vandoorne K, Addadi Y, Neeman M (2010) Visualizing vascular permeability and lymphatic drainage using labeled serum albumin. Angiogenesis 13(2):75\u201385. doi:\n                    10.1007\/s10456-010-9170-4","journal-title":"Angiogenesis"},{"issue":"8","key":"9263_CR38","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.4049\/jimmunol.0903375","volume":"184","author":"A Porzia","year":"2010","unstructured":"Porzia A, Lanzardo S, Citti A, Cavallo F, Forni G, Santoni A, Galandrini R, Paolini R (2010) Attenuation of PI3K\/Akt-mediated tumorigenic signals through PTEN activation by DNA vaccine-induced anti-ErbB2 antibodies. J Immunol 184(8):4170\u20134177. doi:\n                    10.4049\/jimmunol.0903375","journal-title":"J Immunol"},{"issue":"2","key":"9263_CR39","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ccr.2010.06.014","volume":"18","author":"S Park","year":"2010","unstructured":"Park S, Jiang Z, Mortenson ED, Deng L, Radkevich-Brown O, Yang X, Sattar H, Wang Y, Brown NK, Greene M, Liu Y, Tang J, Wang S, Fu YX (2010) The therapeutic effect of anti-HER2\/neu antibody depends on both innate and adaptive immunity. Cancer Cell 18(2):160\u2013170. doi:\n                    10.1016\/j.ccr.2010.06.014","journal-title":"Cancer Cell"},{"issue":"3","key":"9263_CR40","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1182\/blood-2002-12-3738","volume":"102","author":"S Nair","year":"2003","unstructured":"Nair S, Boczkowski D, Moeller B, Dewhirst M, Vieweg J, Gilboa E (2003) Synergy between tumor immunotherapy and antiangiogenic therapy. Blood 102(3):964\u2013971. doi:\n                    10.1182\/blood-2002-12-3738","journal-title":"Blood"},{"issue":"11","key":"9263_CR41","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1517\/14712590903208883","volume":"9","author":"JI Greenberg","year":"2009","unstructured":"Greenberg JI, Cheresh DA (2009) VEGF as an inhibitor of tumor vessel maturation: implications for cancer therapy. Expert Opin Biol Ther 9(11):1347\u20131356. doi:\n                    10.1517\/14712590903208883","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"9263_CR42","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1152\/physrev.00038.2010","volume":"91","author":"S Goel","year":"2011","unstructured":"Goel S, Duda DG, Xu L, Munn LL, Boucher Y, Fukumura D, Jain RK (2011) Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev 91(3):1071\u20131121. doi:\n                    10.1152\/physrev.00038.2010","journal-title":"Physiol Rev"}],"container-title":["Angiogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-012-9263-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10456-012-9263-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-012-9263-3.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-012-9263-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,7]],"date-time":"2019-04-07T15:51:03Z","timestamp":1554652263000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10456-012-9263-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,17]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["9263"],"URL":"https:\/\/doi.org\/10.1007\/s10456-012-9263-3","relation":{},"ISSN":["0969-6970","1573-7209"],"issn-type":[{"value":"0969-6970","type":"print"},{"value":"1573-7209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,17]]}}}